CARBIOS has received €1.2M of the €11.4M granted by ADEME to
further optimize its unique PET depolymerization process and
guarantee its competitiveness
CARBIOS has received €1.2M of the €11.4M
granted by ADEME to further optimize its unique PET
depolymerization process and guarantee its
competitiveness
Clermont-Ferrand (France), 20 December
2023 (18:00 CET). CARBIOS, (Euronext Growth Paris :
ALCRB), a pioneer in the development and industrialization of
biological technologies to reinvent the life cycle of plastic and
textiles, has received an initial payment of €1.2 million1 from the
French Agency for Ecological Transition (ADEME) for the OPTI-ZYME
research project, carried out in partnership with INRAE2, INSA3 and
CNRS4 via the TWB5 joint service and TBI6 research units, a project
co-funded by the French State as part of France 2030 operated by
ADEME. With CARBIOS' aim to optimize and continuously improve its
unique enzymatic PET depolymerization technology, the 4-year7
OPTI-ZYME project aims to investigate the scientific and technical
levers for improving the competitiveness of the process, optimizing
the necessary investments and reducing its environmental
footprint.
This collaborative R&D program focuses on
the technical and economic optimization of process stages, while
preserving the quality of the monomers obtained. These
optimizations, new developments and the exploration of innovative
solutions should enhance the technology's flexibility with regards
to incoming waste. Raw materials could come from different sources
that are currently rarely or not recycled, notably food trays and
textiles, or a mix of incoming materials. It also aims to limit
input and water consumption, as well as regenerate or reduce
co-products and ultimate residual waste. Finally, it seeks to
support enzyme optimization to maximize the process’ economic
profitability and competitiveness. The project therefore aims to
achieve an overall improvement in performance, combining
efficiency, quality and environmental sustainability, to benefit
the Longlaville plant which is currently under construction, and
future licensed plants.
Emmanuel Ladent, CEO of
CARBIOS: "Innovation is at the heart of all CARBIOS
activities. In our constant drive for technological improvement,
and to support industrial and commercial deployment, we must
continue to innovate at every stage of the process. The targeted
optimizations will improve enzyme performance and contribute to
greater productivity, while reducing production costs and the
environmental impact of the process to meet the economic and
sustainable development challenges of our future licensees. Our aim
is to remain the most attractive offer on the recycling
market".
In May 2023, CARBIOS, the project leader and
coordinator, announced that it had been awarded a total of €11.4M
in funding by the French State as part of France 2030, operated by
ADEME, including €8.2M directly for CARBIOS (€3.2M in grants and
€5M in repayable advances) and €3.2M for its academic partners
INRAE, INSA and CNRS (via the TWB mixed service and TBI research
units). This funding, which is made up of grants and repayable
advances, will be paid out in several instalments over the course
of the project, including an initial instalment of 15%, equivalent
to €1.2 million, received by CARBIOS on 5 December 2023. The first
Monitoring Committee with ADEME for the first key stage of the
project will be held in February 2024 to validate the granting of
the second instalment of funding.
This project 2282D0513-A is funded by the French
State as part of France 2030 operated by ADEME.
###
About CARBIOS:
CARBIOS is a biotech company developing and
industrializing biological solutions to reinvent the life cycle of
plastic and textiles. Inspired by nature, CARBIOS develops
enzyme-based processes to break down plastic with a mission to
avoid plastic and textile pollution, and accelerate the transition
to a circular economy. Its two disruptive technologies for the
biorecycling of PET and the biodegradation of PLA are reaching
industrial and commercial scale. Its biorecycling
demonstration plant has been operational since 2021 and a first
industrial plant, in partnership with Indorama Ventures, is due to
be commissioned in 2025. CARBIOS has received scientific
recognition, notably with the cover of Nature, and is supported by
prestigious brands in the cosmetics, Food & Beverage and
apparel industries to enhance their products’ recyclability and
circularity. Nestlé Waters, PepsiCo and Suntory Beverage & Food
Europe are members of a packaging consortium founded by CARBIOS and
L’Oréal. On, Patagonia, PUMA, PVH Corp. and Salomon collaborate
with CARBIOS in a textile consortium.
Visit www.carbios.com/en to find out more about
biotechnology powering plastic and textile circularity.
Twitter: CARBIOS / LinkedIn: CARBIOS /
Instagram: insideCarbios
Information on CARBIOS
shares:
ISIN Code
FR0011648716Ticker
Code
Euronext
Growth: ALCRBLEI:
969500M2RCIWO4NO5F08
CARBIOS, founded in 2011 by Truffle Capital, is eligible for the
PEA-PME, a government program allowing French residents investing
in SMEs to benefit from income tax rebates.
This press release and the information contained
herein do not constitute an offer to sell or a solicitation of an
offer to buy or subscribe to shares in CARBIOS in any country.
Disclaimer on forward-looking statements
and risk factors:
This press release contains forward-looking
statements, not historical data, and should not be construed as a
guarantee that the facts and data stated will occur. These
forward-looking statements are based on data, assumptions and
estimates considered reasonable by CARBIOS. CARBIOS operates in a
competitive and rapidly evolving environment. It is therefore not
in a position to anticipate all risks, uncertainties or other
factors that may affect its business, their potential impact on its
business or the extent to which the materialization of a risk or
combination of risks could lead to results that differ
significantly from those mentioned in any forward-looking
statement. CARBIOS draws your attention to the fact that
forward-looking statements are in no way a guarantee of its future
performance and that its actual financial position, results and
cash flows and the development of the sector in which CARBIOS
operates may differ significantly from those proposed or suggested
by the forward-looking statements contained in this document. In
addition, even if CARBIOS’ financial position, results, cash flows
and developments in the industry in which it operates are
consistent with the forward-looking information contained in this
document, such results or developments may not be a reliable
indication of CARBIOS’ future results or developments. Readers are
advised to carefully consider the risk factors described in the
Universal registration document filed with the French Market
Authority (“AMF”), as well as in the half-year financial report
available free of charge on the Company’s website. Should all or
any part of these risk factors materialize or others, in no case
whatsoever will CARBIOS be liable to anyone for any decision made
or action taken in conjunction with the information and/or
statements in this press release or for any related damages. This
information is given only as of the date of this press release.
CARBIOS makes no commitment to publish updates to this information
or on the assumptions on which it is based, except in accordance
with any legal or regulatory obligation applicable to it.
For additional information, please
contact:
CARBIOSMelissa FlauraudPress
Relationsmelissa.flauraud@carbios.com +33 (0)6 30 26 50
04Benjamin AudebertInvestor
Relationscontact@carbios.com+33 (0)4 73 86 51 76 |
Press Relations
(France)IconicMarie-Virginie
Kleinmvk@iconic-conseil.com+33 (0)1 44 14 99 96 |
Press Relations (U.S.)Rooney
PartnersKate L.
Barrettekbarrette@rooneyco.com+1 212 223 0561 |
Press Relations (DACH & UK)MC
ServicesAnne Henneckecarbios@mc-services.eu+49 (0)211 529
252 22 |
Translation is for information purposes only. In
case of discrepancy between the French and the English version of
this press release, the French version shall prevail
1 Payment of €1,224,233 advance received by CARBIOS on 5
December 20232 French National Research Institute for Agriculture,
Food and the Environment3 French National Institute of Applied
Sciences4 French National Center for Scientific Research5 Toulouse
White Biotechnology - UMS INRAE 1337 / UAR CNRS 35826 Toulouse
Biotechnology Institute - UMR INSA/CNRS 5504 / UMR INSA/INRAE 7927
From 2 January 2023 to 31 December 2026
- 2023 12 20_PR_1st instalment Optizyme_EN_FINAL
Carbios (EU:ALCRB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Carbios (EU:ALCRB)
Historical Stock Chart
From Sep 2023 to Sep 2024